Effects of the intracerebroventricular atrial natriuretic factor on angiotensin II or sodium-induced blood pressure elevation and natriuresis. 1989

K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
Division of Hypertension and Nephrology, National Cardiovascular Center, Osaka, Japan.

We examined the effects of intracerebroventricular (i.c.v.) administration of atrial natriuretic factor (ANF) on pressor and natriuretic responses induced by i.c.v. angiotensin II (Ang II) or hypertonic NaCl in conscious male Wistar rats. The i.c.v. artificial cerebrospinal fluid (CSF) or ANF alone did not cause recognizable changes in mean blood pressure (MBP), urinary volume (UV), or sodium excretion (UNaV). The i.c.v. Ang II or 0.6 M NaCl raised MBP, decreased UV, and increased UNaV. When ANF was administered with Ang II, the Ang II-induced changes in MBP, UV, and UNaV were diminished significantly. ANF also opposed the effects of 0.6 m NaCl, though the effect was significant only in the case of blood pressure. Our results indicate that brain ANF may have antipressor and anti-natriuretic roles.

UI MeSH Term Description Entries
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008297 Male Males
D009318 Natriuresis Sodium excretion by URINATION. Natriureses
D009320 Atrial Natriuretic Factor A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS. ANF,ANP,Atrial Natriuretic Peptide,Atrial Natriuretic Peptides,Atriopeptins,Auriculin,Natriuretic Peptides, Atrial,ANF (1-126),ANF (1-28),ANF (99-126),ANF Precursors,ANP (1-126),ANP (1-28),ANP Prohormone (99-126),ANP-(99-126),Atrial Natriuretic Factor (1-126),Atrial Natriuretic Factor (1-28),Atrial Natriuretic Factor (99-126),Atrial Natriuretic Factor Precursors,Atrial Natriuretic Factor Prohormone,Atrial Natriuretic Peptide (1-126),Atrial Pronatriodilatin,Atriopeptigen,Atriopeptin (1-28),Atriopeptin (99-126),Atriopeptin 126,Atriopeptin Prohormone (1-126),Cardiodilatin (99-126),Cardiodilatin Precursor,Cardionatrin I,Cardionatrin IV,Prepro-ANP,Prepro-CDD-ANF,Prepro-Cardiodilatin-Atrial Natriuretic Factor,Pro-ANF,ProANF,Proatrial Natriuretic Factor,Pronatriodilatin,alpha ANP,alpha-ANP Dimer,alpha-Atrial Natriuretic Peptide,beta-ANP,beta-Atrial Natriuretic Peptide,gamma ANP (99-126),gamma-Atrial Natriuretic Peptide,Natriuretic Peptide, Atrial,Peptide, Atrial Natriuretic,Peptides, Atrial Natriuretic,Prepro ANP,Prepro CDD ANF,Prepro Cardiodilatin Atrial Natriuretic Factor,Pro ANF,alpha ANP Dimer,alpha Atrial Natriuretic Peptide,beta ANP,beta Atrial Natriuretic Peptide,gamma Atrial Natriuretic Peptide
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
May 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
August 1987, The American journal of physiology,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
January 1988, Clinical therapeutics,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
November 1989, Brain research,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
June 1986, Federation proceedings,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
May 1991, Journal of hypertension,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
November 1989, The American journal of physiology,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
December 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
January 1986, The New England journal of medicine,
K Yoshida, and Y Kawano, and Y Hirata, and M Kawamura, and M Kuramochi, and T Omae
August 1997, Clinical nephrology,
Copied contents to your clipboard!